NCT07321964 The Effect of a Digital MediYoga Program on Quality of Life, Blood Pressure and Heart Rate Among Patients With Atrial Fibrillation
| NCT ID | NCT07321964 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Herlev and Gentofte Hospital |
| Condition | Atrial Fibrillation (AF) |
| Study Type | INTERVENTIONAL |
| Enrollment | 456 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 456 participants in total. It began in 2025-09-01 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Atrial fibrillation (AF) is the most common cardiac arrythmia, associated with increased risk of stroke, heart failure, reduced quality of life (QoL), and psychological distress. This randomized controlled trial investigates the effect of MediYoga - a program incorporating deep breathing, low-intensity yoga, and meditation- on disease-specific QoL, blood pressure, and heart rate in 456 patients with paroxysmal AF. With a strong focus on sustainability, the study is fully digital: participants are recruited online, and the 12-week intervention is delivered through an application to smartphone. Additionally, the participants receive online support via Teams. Data will be collected at baseline, 3, 6, and 12 months. The primary outcome is disease specific QoL; secondary outcomes include blood pressure, heart rate, generic QoL, and psychological wellbeing. Qualitative interviews will explore patients' experiences with the intervention.
Eligibility Criteria
Inclusion Criteria: * Aged 18 and above * Diagnosed with paroxysmal atrial fibrillation * EHRA score at 2 or more * Owner of a smartphone or tablet * Speaking and reading Danish * No comorbidity that restricts them from participating in the intervention Exclusion Criteria: * Elevated TSH Hormone * Participated in mindfulness or yoga exercise regularly at any point during the last two years.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07321964 clinical trial?
This trial is open to participants of all sexes, studying Atrial Fibrillation (AF). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07321964 currently recruiting?
Yes, NCT07321964 is actively recruiting participants. Contact the research team at signe.stelling.risom@regionh.dk for enrollment information.
Where is the NCT07321964 trial being conducted?
This trial is being conducted at Herlev, Denmark.
Who is sponsoring the NCT07321964 clinical trial?
NCT07321964 is sponsored by Herlev and Gentofte Hospital. The trial plans to enroll 456 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.